{"id":654,"date":"2026-02-28T14:29:26","date_gmt":"2026-02-28T14:29:26","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/sa-node-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T14:29:26","modified_gmt":"2026-02-28T14:29:26","slug":"sa-node-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/sa-node-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"SA Node: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">SA Node Introduction (What it is)<\/h2>\n\n\n\n<p>The SA Node is the heart\u2019s natural pacemaker.<br\/>\nIt is an anatomy structure made of specialized electrical cells in the right atrium.<br\/>\nIt initiates most normal heartbeats and helps set resting and exercise heart rate.<br\/>\nIt is commonly discussed in electrocardiogram (ECG) interpretation, arrhythmias, and pacemaker decisions.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why SA Node matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>The SA Node matters because it usually determines whether the heart is in <strong>sinus rhythm<\/strong>, the normal rhythm pattern seen on ECG. A clear understanding of SA Node function helps learners interpret common findings such as sinus bradycardia (slow sinus rhythm), sinus tachycardia (fast sinus rhythm), and sinus pauses.<\/p>\n\n\n\n<p>Clinically, problems involving the SA Node can contribute to symptoms like dizziness, presyncope\/syncope (near-fainting\/fainting), fatigue, and exercise intolerance. SA Node dysfunction can also complicate other cardiac conditions by making heart rate management less predictable\u2014for example, when rate-slowing medications are needed for atrial fibrillation (AF) or ischemic heart disease.<\/p>\n\n\n\n<p>From a care-planning perspective, recognizing whether a rhythm disturbance originates from impaired SA Node automaticity, impaired conduction out of the node, or external influences (medications, autonomic tone, metabolic issues) can guide next diagnostic steps. It also informs risk discussions and follow-up planning, including when pacing may be considered in symptomatic bradyarrhythmias.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>The SA Node itself is a single anatomic structure rather than a disease category with stages. However, SA Node\u2013related clinical patterns are commonly grouped into functional and rhythm-based entities:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sinus bradycardia<\/strong>: A sinus rhythm with a slower-than-expected rate for the context (often physiologic in athletes or sleep; sometimes pathologic).<\/li>\n<li><strong>Sinus tachycardia<\/strong>: A sinus rhythm with a faster-than-expected rate for the context (often physiologic with fever, pain, anxiety, anemia, hypovolemia; sometimes inappropriate).<\/li>\n<li><strong>Sinus pause \/ sinus arrest<\/strong>: A transient absence of SA Node impulse formation (or failure of impulses to appear on ECG), leading to a pause that may be rescued by a junctional or ventricular escape rhythm.<\/li>\n<li><strong>SA exit block<\/strong>: The SA Node generates impulses, but conduction from the node to atrial tissue is intermittently blocked, producing \u201cdropped\u201d P waves on ECG patterns consistent with exit block.<\/li>\n<li><strong>Sick sinus syndrome (sinus node dysfunction)<\/strong>: An umbrella term for clinically significant SA Node dysfunction, often age-related or structural, that may include bradycardia, pauses, and <strong>tachy-brady syndrome<\/strong> (alternating atrial tachyarrhythmias such as AF with slow sinus or pauses).<\/li>\n<li><strong>Chronotropic incompetence<\/strong>: Inadequate heart rate increase with exertion due to impaired SA Node response and\/or autonomic regulation.<\/li>\n<li><strong>Inappropriate sinus tachycardia (IST)<\/strong>: Persistently elevated sinus rates out of proportion to physiologic demand, after secondary causes are excluded (definitions and evaluation approaches vary by clinician and case).<\/li>\n<\/ul>\n\n\n\n<p>There are also <strong>normal variants<\/strong> in pacemaker location within the right atrium. The dominant pacemaker can shift slightly along the high right atrium depending on autonomic tone, atrial stretch, and other influences, without implying disease.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p><strong>Location and structure<\/strong><br\/>\nThe SA Node (sinoatrial node) lies in the <strong>right atrium<\/strong>, typically near the junction of the <strong>superior vena cava (SVC)<\/strong> and the right atrial appendage, along the region of the <strong>crista terminalis<\/strong>. It is composed of specialized pacemaker cells distinct from working atrial myocardium. These cells have fewer organized contractile elements and are optimized for impulse initiation rather than force generation.<\/p>\n\n\n\n<p><strong>Blood supply<\/strong><br\/>\nThe SA Node is supplied by the <strong>SA nodal artery<\/strong>, which most commonly arises from the <strong>right coronary artery (RCA)<\/strong>, and less commonly from the <strong>left circumflex artery (LCx)<\/strong>. Coronary anatomy varies among individuals, which influences vulnerability to ischemia in certain coronary syndromes.<\/p>\n\n\n\n<p><strong>Role in the cardiac conduction system<\/strong><br\/>\nThe SA Node initiates the electrical impulse that spreads through the atria, producing atrial depolarization and the <strong>P wave<\/strong> on the surface ECG. The impulse then reaches the <strong>atrioventricular (AV) node<\/strong>, travels through the <strong>His-Purkinje system<\/strong>, and depolarizes the ventricles (QRS complex). While the SA Node sets the pace under normal conditions, the AV junction and ventricles have intrinsic escape pacemaker capabilities if the SA Node fails or conduction is blocked.<\/p>\n\n\n\n<p><strong>Automaticity and autonomic control<\/strong><br\/>\nSA Node pacemaker activity depends on spontaneous diastolic depolarization driven by multiple ionic currents, including the \u201cfunny\u201d current (If) and calcium currents. Heart rate is dynamically modulated by:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sympathetic stimulation (\u03b2-adrenergic effects)<\/strong>: generally increases SA Node firing and conduction, raising heart rate and enhancing chronotropic response to exercise.<\/li>\n<li><strong>Parasympathetic (vagal) stimulation<\/strong>: generally decreases SA Node firing and can slow conduction, lowering heart rate and increasing susceptibility to pauses in some settings.<\/li>\n<\/ul>\n\n\n\n<p>This physiologic modulation is why sinus rates vary with sleep, fitness, emotional state, temperature, intravascular volume, and many systemic illnesses.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>SA Node\u2013related problems typically arise from one or more of the following mechanisms, which can overlap:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\n<p><strong>Reduced automaticity (impulse generation problem)<\/strong><br\/>\n  The SA Node fires more slowly or intermittently fails to initiate impulses. Common contributors include age-related fibrosis, ischemia, infiltrative processes, and medication effects. Autonomic imbalance can also suppress automaticity (e.g., high vagal tone).<\/p>\n<\/li>\n<li>\n<p><strong>Impaired impulse exit from the node (conduction problem)<\/strong><br\/>\n  The SA Node may generate impulses normally, but they intermittently fail to propagate into atrial tissue (SA exit block). On ECG this can appear as \u201cmissing\u201d P waves with pause patterns that may suggest blocked exit rather than absent generation.<\/p>\n<\/li>\n<li>\n<p><strong>Atrial remodeling and the \u201ctachy-brady\u201d spectrum<\/strong><br\/>\n  Atrial fibrosis and electrical remodeling can support atrial tachyarrhythmias (like AF or atrial flutter) and also impair sinus node function. Following termination of a tachyarrhythmia, the SA Node may be slow to recover, producing long pauses (post-conversion pauses). The mechanism can include both intrinsic node dysfunction and overdrive suppression.<\/p>\n<\/li>\n<li>\n<p><strong>Chronotropic incompetence<\/strong><br\/>\n  The SA Node may not appropriately increase its firing rate with exertion, due to intrinsic disease, autonomic dysfunction, medication effects (e.g., beta-blockers), or a combination. The practical consequence is limited cardiac output augmentation during exercise.<\/p>\n<\/li>\n<li>\n<p><strong>Inappropriate sinus tachycardia mechanisms (variable)<\/strong><br\/>\n  Proposed mechanisms include heightened sympathetic drive, reduced parasympathetic tone, intrinsic pacemaker hypersensitivity, or dysautonomia. Evaluation and classification vary by protocol and patient factors, and diagnosis generally requires exclusion of secondary causes of sinus tachycardia.<\/p>\n<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>Because the SA Node is an anatomic structure, it is not \u201cindicated\u201d like a test or drug. Instead, it is encountered in typical clinical scenarios such as:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Incidental ECG finding<\/strong> of sinus bradycardia or sinus tachycardia during routine exams, pre-operative evaluation, or urgent care visits.<\/li>\n<li><strong>Symptoms suggesting bradyarrhythmia<\/strong>, including lightheadedness, fatigue, reduced exercise tolerance, presyncope, or syncope.<\/li>\n<li><strong>Palpitations<\/strong> with a documented sinus rhythm (e.g., sinus tachycardia) versus palpitations from non-sinus rhythms.<\/li>\n<li><strong>Post-tachyarrhythmia pauses<\/strong>, such as after spontaneous or treatment-related conversion from AF\/flutter to sinus rhythm.<\/li>\n<li><strong>Medication-related rate issues<\/strong>, for example bradycardia associated with beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, certain antiarrhythmics, or sedatives (context-dependent).<\/li>\n<li><strong>Ischemic presentations<\/strong> where nodal ischemia is possible (e.g., inferior myocardial infarction can be associated with sinus bradycardia via ischemia and\/or increased vagal tone).<\/li>\n<li><strong>Post\u2013cardiac surgery or catheter ablation<\/strong> scenarios where transient or persistent sinus node dysfunction can occur.<\/li>\n<li><strong>Exercise testing<\/strong> prompted by exertional symptoms where chronotropic incompetence is suspected.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>Evaluation focuses on confirming the rhythm, linking rhythm disturbances to symptoms, and assessing reversible contributors. Common components include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>History and medication review<\/strong><\/li>\n<li>Timing and triggers of symptoms (rest, exertion, sleep, post-prandial).<\/li>\n<li>Review for rate-slowing or pro-arrhythmic drugs and recent medication changes.<\/li>\n<li>\n<p>Screening for systemic contributors (fever, dehydration, anemia symptoms, thyroid disease symptoms, sleep issues).<\/p>\n<\/li>\n<li>\n<p><strong>Physical examination<\/strong><\/p>\n<\/li>\n<li>Vital signs (including orthostatic measurements in appropriate contexts).<\/li>\n<li>Signs of systemic illness, volume status, or heart failure (context-dependent).<\/li>\n<li>\n<p>Assessment for bradycardia-related hypoperfusion signs during symptomatic episodes.<\/p>\n<\/li>\n<li>\n<p><strong>Electrocardiogram (ECG)<\/strong><\/p>\n<\/li>\n<li>Identification of <strong>sinus rhythm<\/strong>: P waves with consistent morphology preceding each QRS and a stable PR interval (general pattern).<\/li>\n<li>Recognition of <strong>sinus pauses\/arrest<\/strong>: absent P waves for a period with or without an escape rhythm.<\/li>\n<li>Consideration of <strong>SA exit block<\/strong> patterns (interpretation can be challenging and varies with tracing quality and clinical context).<\/li>\n<li>\n<p>Distinguishing sinus tachycardia from atrial tachycardia, atrial flutter, and AF.<\/p>\n<\/li>\n<li>\n<p><strong>Ambulatory rhythm monitoring<\/strong><\/p>\n<\/li>\n<li>Holter monitors, patch monitors, event monitors, or implantable loop recorders may be used to correlate intermittent symptoms with rhythm disturbances.<\/li>\n<li>\n<p>Clinicians generally look for symptom\u2013rhythm correlation, frequency and pattern of pauses, and presence of atrial tachyarrhythmias.<\/p>\n<\/li>\n<li>\n<p><strong>Laboratory testing (selected based on context)<\/strong><\/p>\n<\/li>\n<li>Thyroid function, electrolytes, and other tests may be considered when evaluating unexplained bradycardia\/tachycardia or arrhythmia susceptibility.<\/li>\n<li>\n<p>The exact workup varies by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Echocardiography (when indicated)<\/strong><\/p>\n<\/li>\n<li>\n<p>Assesses structural heart disease (chamber size, ventricular function, valvular disease) that can coexist with atrial arrhythmias and influence management planning.<\/p>\n<\/li>\n<li>\n<p><strong>Exercise testing<\/strong><\/p>\n<\/li>\n<li>Can support assessment of chronotropic response and symptom reproduction.<\/li>\n<li>\n<p>Interpretation depends on patient fitness, medications, and protocol.<\/p>\n<\/li>\n<li>\n<p><strong>Electrophysiology (EP) evaluation<\/strong><\/p>\n<\/li>\n<li>In selected cases, invasive EP testing may be used to clarify mechanism, though many patients are diagnosed with noninvasive tools. Use varies by protocol and patient factors.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>Management is guided by symptoms, hemodynamic impact, rhythm documentation, and whether contributors are reversible. Educationally, it helps to think in layers rather than a single pathway:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Address contributing factors<\/strong><\/li>\n<li>Review and adjust potentially causative medications when appropriate to the clinical situation.<\/li>\n<li>Treat underlying systemic triggers of sinus tachycardia (e.g., fever, anemia, volume depletion) when identified.<\/li>\n<li>Evaluate for and manage contributing conditions such as sleep-disordered breathing or thyroid disease when relevant.<\/li>\n<li>\n<p>The specific sequence and urgency depend on presentation and setting.<\/p>\n<\/li>\n<li>\n<p><strong>Observation and follow-up<\/strong><\/p>\n<\/li>\n<li>Asymptomatic sinus bradycardia can be physiologic (e.g., athletic conditioning, sleep) and may require only recognition and periodic reassessment.<\/li>\n<li>\n<p>Similarly, sinus tachycardia can be an appropriate physiologic response; the priority is often identifying the driver.<\/p>\n<\/li>\n<li>\n<p><strong>Management of symptomatic sinus node dysfunction<\/strong><\/p>\n<\/li>\n<li>When symptoms are attributable to documented bradycardia, pauses, or chronotropic incompetence, clinicians may consider pacing strategies. Permanent pacemaker therapy is a common long-term option for significant symptomatic bradyarrhythmias related to SA Node dysfunction.<\/li>\n<li>\n<p>Decisions incorporate symptom burden, correlation with rhythm findings, comorbidities, and patient goals; thresholds and approaches vary by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Managing the tachy-brady spectrum<\/strong><\/p>\n<\/li>\n<li>If atrial tachyarrhythmias coexist (e.g., AF with long post-conversion pauses), care plans often address both the tachyarrhythmia and the bradyarrhythmia risk.<\/li>\n<li>\n<p>In some patients, pacemaker implantation can enable safer use of rate-slowing or rhythm-control therapies by reducing bradycardia limitations (strategy and sequencing vary by protocol and patient factors).<\/p>\n<\/li>\n<li>\n<p><strong>Inappropriate sinus tachycardia (when suspected)<\/strong><\/p>\n<\/li>\n<li>Management typically starts with confirming sinus mechanism and excluding secondary causes.<\/li>\n<li>Lifestyle factors, autonomic modulation strategies, and medications may be considered depending on clinician judgment; invasive approaches such as sinus node modification\/ablation are reserved for selected cases due to variable efficacy and potential risks.<\/li>\n<\/ul>\n\n\n\n<p>This section is informational only; treatment choices and timing depend heavily on presentation and clinician assessment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>Key complications and limitations relate to SA Node dysfunction itself and to common downstream interventions:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Clinical risks of SA Node dysfunction<\/strong><\/li>\n<li>Syncope or presyncope from prolonged pauses or inadequate heart rate response.<\/li>\n<li>Reduced exercise capacity from chronotropic incompetence.<\/li>\n<li>\n<p>Coexisting atrial tachyarrhythmias that may increase symptom burden and complicate rate control strategies.<\/p>\n<\/li>\n<li>\n<p><strong>ECG and monitoring limitations<\/strong><\/p>\n<\/li>\n<li>Intermittent symptoms may be difficult to capture; longer monitoring is sometimes needed.<\/li>\n<li>\n<p>Distinguishing sinus pauses from SA exit block, or sinus tachycardia from atrial tachycardia, can be challenging on limited tracings.<\/p>\n<\/li>\n<li>\n<p><strong>Medication-related limitations<\/strong><\/p>\n<\/li>\n<li>Drugs used for angina, hypertension, or arrhythmia control may worsen bradycardia in susceptible patients.<\/li>\n<li>\n<p>Medication decisions often require balancing competing goals (symptom control, ischemia management, arrhythmia suppression).<\/p>\n<\/li>\n<li>\n<p><strong>Pacemaker-related risks (context-dependent)<\/strong><\/p>\n<\/li>\n<li>Procedure-related complications (infection, bleeding\/hematoma, lead displacement, pneumothorax) can occur.<\/li>\n<li>Long-term issues can include lead malfunction, device replacement needs, and device\u2013patient interactions (e.g., pacing dependence in some contexts).<\/li>\n<li>\n<p>Device programming to match physiologic needs (including rate-responsive pacing for chronotropic incompetence) may require follow-up adjustments.<\/p>\n<\/li>\n<li>\n<p><strong>Ablation-related risks (selected scenarios)<\/strong><\/p>\n<\/li>\n<li>When considered for inappropriate sinus tachycardia, sinus node modification\/ablation can carry risks such as creating or worsening bradycardia, sometimes leading to pacemaker requirement. Outcomes vary by protocol and patient factors.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Prognosis depends less on the SA Node as a structure and more on the <strong>underlying cause<\/strong>, symptom severity, and associated cardiac disease:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Physiologic sinus bradycardia\/tachycardia<\/strong> often has a benign outlook when clearly linked to normal triggers and without concerning symptoms, though follow-up depends on the broader clinical picture.<\/li>\n<li><strong>Sinus node dysfunction<\/strong> related to fibrosis\/aging can be chronic and may progress over time. Many patients have good symptom control when the rhythm problem is clearly identified and managed appropriately, including with pacing when indicated.<\/li>\n<li><strong>Comorbid conditions<\/strong> (structural heart disease, coronary disease, heart failure, atrial arrhythmias, sleep-disordered breathing) frequently influence symptom burden, hospitalization risk, and monitoring intensity.<\/li>\n<li><strong>Follow-up<\/strong> commonly includes reassessment of symptoms, periodic ECG review, and review of medication effects. If a pacemaker is used, device checks and programming optimization are central to long-term care.<\/li>\n<li><strong>Patient-centered factors<\/strong>\u2014activity goals, occupation, tolerance of symptoms, and access to monitoring\u2014often shape follow-up strategies. Specific schedules vary by clinician and case.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">SA Node Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does SA Node stand for, and what does it do?<\/strong><br\/>\nThe SA Node refers to the sinoatrial node, a cluster of specialized cells in the right atrium. It normally initiates each heartbeat and sets the pace for sinus rhythm. Its rate is continuously adjusted by the autonomic nervous system and physiologic demands.<\/p>\n\n\n\n<p><strong>Q: Is the SA Node the same thing as sinus rhythm?<\/strong><br\/>\nThey are related but not identical. The SA Node is the anatomic pacemaker, while sinus rhythm is the ECG pattern that results when atrial activation starts from the SA Node and spreads normally. A person can have non-sinus rhythms even though the SA Node is present.<\/p>\n\n\n\n<p><strong>Q: What is \u201csick sinus syndrome\u201d?<\/strong><br\/>\nSick sinus syndrome (also called sinus node dysfunction) is a clinical umbrella term for SA Node problems that cause symptomatic bradycardia, pauses, chronotropic incompetence, or alternating slow and fast atrial rhythms (tachy-brady syndrome). It is commonly associated with age-related atrial fibrosis but can have other causes. Diagnosis usually requires correlating symptoms with documented rhythm abnormalities.<\/p>\n\n\n\n<p><strong>Q: Can SA Node problems cause fainting?<\/strong><br\/>\nThey can contribute to syncope if pauses are prolonged or if the heart rate cannot increase enough to maintain blood pressure during posture changes or exertion. However, fainting has many potential causes, including vasovagal episodes and non-cardiac conditions. Clinicians typically aim to document rhythm during symptoms to clarify the mechanism.<\/p>\n\n\n\n<p><strong>Q: How do clinicians evaluate SA Node function?<\/strong><br\/>\nEvaluation often starts with an ECG and a careful history, including medications and symptom triggers. Because SA Node abnormalities can be intermittent, ambulatory monitoring is commonly used to capture events. Additional testing (labs, echocardiography, exercise testing, or electrophysiology evaluation) may be used depending on the scenario.<\/p>\n\n\n\n<p><strong>Q: Does a pacemaker \u201creplace\u201d the SA Node?<\/strong><br\/>\nA pacemaker does not remove the SA Node; it provides electrical stimulation when the heart\u2019s intrinsic rhythm is too slow or pauses occur. Many pacemakers are programmed to allow the heart\u2019s own rhythm when it is adequate and to pace only when needed. Device behavior and programming depend on clinical goals and patient factors.<\/p>\n\n\n\n<p><strong>Q: Is sinus bradycardia always abnormal?<\/strong><br\/>\nNot necessarily. Sinus bradycardia can be normal in healthy individuals, during sleep, and in well-trained athletes. Whether it is concerning depends on symptoms, context (e.g., illness or medications), and associated ECG findings; interpretation varies by clinician and case.<\/p>\n\n\n\n<p><strong>Q: What is chronotropic incompetence, and why does it matter?<\/strong><br\/>\nChronotropic incompetence means the heart rate does not rise appropriately with activity. This can limit exercise capacity because cardiac output may not increase enough to meet metabolic demand. It may reflect intrinsic SA Node dysfunction, medication effects, or autonomic factors, and is often evaluated with exercise testing and clinical correlation.<\/p>\n\n\n\n<p><strong>Q: What are typical next steps after finding sinus pauses or SA Node dysfunction on monitoring?<\/strong><br\/>\nClinicians usually confirm that symptoms align with the rhythm findings and assess for reversible contributors such as medications or metabolic issues. They also evaluate for associated atrial arrhythmias and structural heart disease when relevant. Longer-term planning may include observation, medication adjustments, or pacing strategies depending on severity and patient-specific considerations.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The SA Node is the heart\u2019s natural pacemaker. It is an anatomy structure made of specialized electrical cells in the right atrium. It initiates most normal heartbeats and helps set resting and exercise heart rate. It is commonly discussed in electrocardiogram (ECG) interpretation, arrhythmias, and pacemaker decisions.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-654","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=654"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/654\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}